# Reducing Blood Loss Using Tisseel in TKA

> **NCT03310060** · PHASE4 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Total Blood Loss

## Interventions

- **DRUG:** Tisseel
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT03310060
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03310060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03310060, "Reducing Blood Loss Using Tisseel in TKA". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03310060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*